Female Healthy Volunteers (Ages 16 to 40) - Valley Village CA (Metro Los Angeles)

Summary:

Click image to enlarge

CMVictory Trial is a clinical trial for an investigational vaccine to protect against CMV (Cytomegalovirus) infection. This clinical trial is sponsored by Moderna. Moderna is studying mRNA-1647, an investigational vaccine, to understand whether it can help your immune system protect against cytomegalovirus (CMV). The purpose of this study is to:

1.    Evaluate the safety and efficacy of investigational vaccine (not yet been approved by FDA), mRNA-1647 against CMV.
2.   Evaluate the safety of the vaccine in women who test positive prior exposure to CMV.

What is CMV? 

Cytomegalovirus, shortened to CMV, is a leading cause of birth defects around the world. CMV is a common viral infection that usually goes unnoticed or only causes mild symptoms in most people. But if a woman becomes infected with CMV while she is pregnant, she can pass the infection to her unborn baby. This can cause her child to suffer long-term disability due to birth defects, including hearing loss, or even death in very severe cases. Currently, there is no approved vaccine against CMV. CMV is the #1 infection that causes birth defects in the U.S. and one of the most common infectious causes of birth defects globally.  

This is your chance to help!! 

1. You must be biological female between the age of 16-40
2. You must be in good health
3. You must have close contact with at least one child 5 years of age or younger for at least 8 hours a week
4. You must be Not Pregnant or planning on becoming pregnant within the next 9 months. 

Qualified Participants May Receive:

1. $100 per each completed clinic visit - 14 clinic visit in 30 months
2. $10 per each eDiary safety qusetionnaire - about 20-21 survey in 30 months
3. Clinical trial participant will have a screneing visit to check wheather they are eligible to partcipate. The visit includes a wellness exam with an M.D., review of your medical history, a urine pregnancy test and blood test to see if you have CMV infection. 
4. Double blinded with 1:1 ratio with 50% chance receiving the actual vaccine vs. 50% chance receiving the placebo vaccine, 3 vaccine injections within 6 months period. 
5. Once the participant officially enrolled into the study, the Sponsor may provide transportation if needed.